Pharma's Almanac reposted this
The adoption of artificial intelligence (AI) and machine learning in the pharma industry is accelerating at a remarkable pace. Join us for this Pharma's Almanac roundtable, where a panel of industry experts shares insights on the most exciting advancements in AI and machine learning within biopharma. Read the roundtable here: https://lnkd.in/grWQjEKG Our roundtable includes contributors from Actylis, Alconox Inc., Corning Life Sciences, Dynamk Capital, Envisagenics, GBI Bio, Mikart, LLC, Nu-Tek BioSciences, PCI Pharma Services, Porton Advanced │ Cell & Gene Therapy CDMO/CRO, Samsung Biologics, Vectron Biosolutions AS, CRB, eClinical Solutions, Enthought, Newfront, OM1, Inc., Faeth Therapeutics, MedPharm, ScaleReady, Catalent Pharma Solutions, Merck KGaA, Darmstadt, Germany, Seer, Terumo Blood and Cell Technologies, LabVantage Solutions, Inc, VIDA, Karius, Rani Therapeutics, Rune Labs, Sherlock Biosciences, Opentrons Labworks Inc., Epocrates Inc, VintaBio, Charles River Laboratories, Omega Therapeutics, Ethris, Elixirgen Therapeutics, Inc., Anima Biotech, Alto Neuroscience, Be The Match BioTherapies... (cont) #AI #Machinelearning #Pharma #Roundtable
(cont)... MFX, and Sterling Pharma Solutions
Thanks to our distinguished panel of experts: Ed Roullard, Marius Dräger, Benjamin Josey, Sebastien Latapie, Martin Akerman, Muctarr Sesay, Michael Kallelis, Chris Wiedel, Shawn Cain, Ihab Judeh, PhD, MBA, Jiwoong Park, Trond Erik Vee Aune, Ryan Thompson, Raj Indupuri, James Corson, Cristina Varner, LUTCF, ARM, Joseph Zabinski, Ph.D., Anand Parikh, Lynn Allen, Josh Ludwig, Larry Rushing, Karen Madden, Serafim Batzoglou, Dalip Sethi, PhD, MBA, Lothar Finster, Susan Wood, Sivan Bercovici, Talat Imran, Naveen Kumar, Maurice Exner, Jonathan Brennan-Badal, Bridget Seay, David Radspinner, Mark Mintz, Mahesh Karande, Carsten Rudolph, Dr., Akihiro Ko, Yochi Slonim, Adam Savitz, Chris McClain, Lindsey Clarke, and Richard Perry